PulseAugur
EN
LIVE 15:57:28

Targeted therapy turns advanced lung cancer into chronic illness

By PulseAugur Editorial · [1 sources] ·

A global study co-led by the Chinese University of Hong Kong has demonstrated that the targeted therapy lorlatinib can prevent disease progression in over half of advanced lung cancer patients for at least seven years. This significant advancement suggests the potential to manage advanced lung cancer as a chronic illness, similar to conditions like diabetes. The research involved 296 patients across multiple regions, comparing lorlatinib against crizotinib, with the former showing a 55% progression-free survival rate at seven years versus 3% for the control. AI

RANK_REASON The cluster reports on findings from a clinical trial published in a study, which is a research milestone. [lever_c_demoted from research: ic=1 ai=0.1]

Read on SCMP — Tech →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Targeted therapy turns advanced lung cancer into chronic illness

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster reports on findings from a clinical trial published in a study, which is a research milestone. [lever_c_demoted from research: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
paper, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
119 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. SCMP — Tech TIER_1 English(EN) · Fiona Sun ·

    Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study

    A Hong Kong co-led global study has found that a targeted therapy can keep more than half of advanced lung cancer patients alive without disease progression for at least seven years, marking a step towards turning the deadly illness into a chronic condition. Researchers from the …

RELATED ENTITIES

RELATED TOPICS